WebHoward Soule, PhD, has served as the executive vice president and chief science officer of the Prostate Cancer Foundation since 1997. In this capacity, Dr. Soule coordinates … Web18 de jun. de 2024 · original reports Event-Free Survival, a Prostate-Specific Antigen–Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With

UNC scientist to partner on nanoparticle vaccine for prostate cancer

WebHoward R. Soule, Ph.D. Executive Vice President Chief Science Officer CapCure 1250 Fourth Street, Suite 360 Santa Monica, CA 90401 Phone: (800) 757-2873 WebMedicine, talked with Howard R. Soule, PhD, Executive Vice President and Chief Science Officer for the Prostate Cancer Foun-dation (PCF; Santa Monica, CA), about the … five guiding principles church of england

Prostate Cancer Foundation Leadership Team

WebHoward R. Soule, PhD, Chief Science Officer and Executive Vice President Stuart Holden, MD, Medical Director Andrea Miyahira, PhD, Director, Global Research and Scientific Communications Development & Translation Committee, PCF Board of Directors Surgical Urologic Oncology William Aronson, MD, University of California, Los Angeles WebHoward Soule, PhD, has served as the executive vice president and chief science officer of the Prostate Cancer Foundation since 1997. In this capacity, Dr. Soule coordinates global academic, government and biopharmaceutical sector research activity and is responsible for the implementation of Prostate Cancer Foundation global research strategies. Web15 de ago. de 2011 · “These newly funded programs form an excellent, patient-centric PCF-funded research portfolio,” reports Howard Soule, PhD, executive vice president and chief science officer for PCF. five guiding principles of vision 2030